$FENC
FENNEC PHARMACEUTICALS INC.

2013 Q2 Form 10-Q Financial Statement

#000114420413044104 Filed on August 09, 2013

View on sec.gov

Income Statement

Concept 2013 Q2 2012 Q2 2012 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $370.0K $390.0K $320.0K
YoY Change -5.13% 14.71% -54.93%
% of Gross Profit
Research & Development $554.0K $860.0K $296.0K
YoY Change -35.58% 267.52% -6.03%
% of Gross Profit
Depreciation & Amortization $0.00 $0.00 $0.00
YoY Change
% of Gross Profit
Operating Expenses $927.0K $1.250M $296.0K
YoY Change -25.84% 118.53% -6.03%
Operating Profit -$927.0K -$1.250M -$616.0K
YoY Change -25.84% 118.53% -39.67%
Interest Expense $0.00 $0.00 $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $7.534M $648.0K $3.331M
YoY Change 1062.65% 189.29% -41.46%
Pretax Income $6.610M -$600.0K $2.720M
YoY Change -1201.67% 71.43% -41.76%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income 0.0% 0.0%
Net Earnings $6.607M -$602.0K $2.715M
YoY Change -1197.51% 72.99% -41.85%
Net Earnings / Revenue
Basic Earnings Per Share $0.11
Diluted Earnings Per Share $773.1K -$71.51K $0.11
COMMON SHARES
Basic Shares Outstanding 25.16M shares 25.16K shares 25.16M shares
Diluted Shares Outstanding 25.64M shares 25.16K shares 25.16M shares

Balance Sheet

Concept 2013 Q2 2012 Q2 2012 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.010M $3.590M $4.720M
YoY Change -71.87% -47.28% -5.98%
Cash & Equivalents $1.007M $3.586M $4.719M
Short-Term Investments
Other Short-Term Assets $3.000K $3.000K $14.00K
YoY Change 0.0% -85.0% -80.0%
Inventory
Prepaid Expenses $20.00K $11.00K $24.00K
Receivables
Other Receivables
Total Short-Term Assets $1.030M $3.600M $4.760M
YoY Change -71.39% -47.29% -37.7%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 -$3.000K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $1.030M $3.600M $4.760M
Total Long-Term Assets $0.00 $0.00 -$3.000K
Total Assets $1.030M $3.600M $4.757M
YoY Change -71.39% -47.29% -37.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $716.0K $276.0K $374.0K
YoY Change 159.42% 15.0% -15.0%
Accrued Expenses $65.00K $173.0K $38.00K
YoY Change -62.43% 476.67% -65.45%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.460M $1.560M $2.160M
YoY Change 121.79% -79.23% -72.73%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.460M $1.560M $2.160M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $3.459M $1.555M $2.162M
YoY Change 122.44% -79.29% -72.7%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $104.4M $104.1M $104.0M
YoY Change 0.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.429M $2.045M $2.595M
YoY Change
Total Liabilities & Shareholders Equity $1.030M $3.600M $4.757M
YoY Change -71.39% -47.29% -37.74%

Cashflow Statement

Concept 2013 Q2 2012 Q2 2012 Q1
OPERATING ACTIVITIES
Net Income $6.607M -$602.0K $2.715M
YoY Change -1197.51% 72.99% -41.85%
Depreciation, Depletion And Amortization $0.00 $0.00 $0.00
YoY Change
Cash From Operating Activities -$889.0K -$1.133M -$578.0K
YoY Change -21.54% -163.94% -44.85%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $0.00
YoY Change
Debt Paid & Issued, Net $0.00 $0.00 $0.00
YoY Change
Cash From Financing Activities $0.00 $0.00 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -$889.0K -$1.133M -578.0K
Cash From Investing Activities $0.00 $0.00 0.000
Cash From Financing Activities $0.00 $0.00 0.000
Net Change In Cash -$889.0K -$1.133M -578.0K
YoY Change -21.54% -163.94% -44.85%
FREE CASH FLOW
Cash From Operating Activities -$889.0K -$1.133M -$578.0K
Capital Expenditures $0.00 $0.00 $0.00
Free Cash Flow -$889.0K -$1.133M -$578.0K
YoY Change -21.54% -163.94% -44.85%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2013-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Trading Symbol
TradingSymbol
ADHXF
CY2013Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25157861 shares
dei Entity Registrant Name
EntityRegistrantName
ADHEREX TECHNOLOGIES INC
dei Entity Central Index Key
EntityCentralIndexKey
0001211583
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2013Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2012Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25158 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25158 shares
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
0 shares
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
0 shares
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1007000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2303000 USD
CY2013Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
20000 USD
CY2012Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
56000 USD
CY2012Q4 us-gaap Other Assets Current
OtherAssetsCurrent
6000 USD
CY2013Q2 us-gaap Assets
Assets
1030000 USD
CY2012Q4 us-gaap Assets
Assets
2365000 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
259000 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
423000 USD
CY2013Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
2678000 USD
CY2012Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
6640000 USD
CY2013Q2 us-gaap Liabilities
Liabilities
3459000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
7322000 USD
CY2013Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
65952000 USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
65952000 USD
CY2013Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
38420000 USD
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
38391000 USD
CY2013Q2 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
108044000 USD
CY2012Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
110543000 USD
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1243000 USD
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
-2429000 USD
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1030000 USD
CY2013Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
554000 USD
CY2012Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
860000 USD
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
732000 USD
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
1157000 USD
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
69900000 USD
dei Document Type
DocumentType
10-Q
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
732000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
710000 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-927000 USD
CY2013Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
65000 USD
CY2013Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
716000 USD
CY2013Q2 us-gaap Other Assets Current
OtherAssetsCurrent
3000 USD
CY2012Q2 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-62000 USD
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-138000 USD
CY2013Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2012Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
386000 USD
CY2013Q2 adhxf Gain On Deferred Lease Inducements
GainOnDeferredLeaseInducements
0 USD
CY2012Q2 adhxf Gain On Deferred Lease Inducements
GainOnDeferredLeaseInducements
0 USD
adhxf Gain On Deferred Lease Inducements
GainOnDeferredLeaseInducements
0 USD
adhxf Gain On Deferred Lease Inducements
GainOnDeferredLeaseInducements
0 USD
adhxf Gain On Deferred Lease Inducements
GainOnDeferredLeaseInducements
497000 USD
CY2013Q2 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
0 USD
CY2012Q2 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
0 USD
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
0 USD
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
0 USD
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
13094000 USD
CY2013Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
373000 USD
CY2012Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
390000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
32826000 USD
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1250000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-1464000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-1867000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-115709000 USD
CY2013Q2 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 USD
CY2012Q2 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-1283000 USD
CY2013Q2 us-gaap Interest Expense
InterestExpense
0 USD
CY2012Q2 us-gaap Interest Expense
InterestExpense
0 USD
us-gaap Interest Expense
InterestExpense
0 USD
us-gaap Interest Expense
InterestExpense
0 USD
us-gaap Interest Expense
InterestExpense
19000 USD
CY2013Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
7535000 USD
CY2012Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
645000 USD
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
3962000 USD
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
3971000 USD
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
7219000 USD
CY2013Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
2000 USD
CY2012Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 USD
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
2000 USD
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 USD
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
261000 USD
CY2013Q2 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
-3000 USD
CY2012Q2 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
3000 USD
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
-1000 USD
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
8000 USD
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
2896000 USD
CY2013Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
7534000 USD
CY2012Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
648000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3963000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3979000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
9074000 USD
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.26
CY2012Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.10
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.08
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
927000 USD
CY2012Q2 us-gaap Operating Expenses
OperatingExpenses
1250000 USD
us-gaap Operating Expenses
OperatingExpenses
1464000 USD
us-gaap Operating Expenses
OperatingExpenses
1867000 USD
CY2012Q2 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
645000 USD
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
3962000 USD
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
3971000 USD
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
7219000 USD
CY2013Q2 adhxf Amortization Of Tenant Inducements Received
AmortizationOfTenantInducementsReceived
0 USD
CY2012Q2 adhxf Amortization Of Tenant Inducements Received
AmortizationOfTenantInducementsReceived
0 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
35000 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
1048000 USD
CY2013Q2 us-gaap Share Based Compensation
ShareBasedCompensation
29000 USD
CY2012Q2 us-gaap Share Based Compensation
ShareBasedCompensation
17000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
29000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
17000 USD
adhxf Amortization Of Tenant Inducements Received
AmortizationOfTenantInducementsReceived
0 USD
adhxf Amortization Of Tenant Inducements Received
AmortizationOfTenantInducementsReceived
0 USD
adhxf Amortization Of Tenant Inducements Received
AmortizationOfTenantInducementsReceived
412000 USD
CY2013Q2 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
0 USD
CY2012Q2 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
0 USD
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
0 USD
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25158 shares
CY2012Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25158 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25158 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25158 shares
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25639 shares
CY2012Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25158 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25714 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25158 shares
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
6607000 USD
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-602000 USD
us-gaap Net Income Loss
NetIncomeLoss
2499000 USD
us-gaap Net Income Loss
NetIncomeLoss
2112000 USD
us-gaap Net Income Loss
NetIncomeLoss
-106635000 USD
us-gaap Operating Expenses
OperatingExpenses
115709000 USD
CY2013Q2 us-gaap Revenues
Revenues
0 USD
CY2012Q2 us-gaap Revenues
Revenues
0 USD
us-gaap Revenues
Revenues
0 USD
us-gaap Revenues
Revenues
0 USD
us-gaap Revenues
Revenues
0 USD
CY2013Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
0 USD
CY2012Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
0 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
0 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
0 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1404000 USD
CY2013Q2 us-gaap Other Noncash Expense
OtherNoncashExpense
0 USD
CY2012Q2 us-gaap Other Noncash Expense
OtherNoncashExpense
0 USD
us-gaap Other Noncash Expense
OtherNoncashExpense
0 USD
us-gaap Other Noncash Expense
OtherNoncashExpense
0 USD
us-gaap Other Noncash Expense
OtherNoncashExpense
1187000 USD
CY2013Q2 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
7535000 USD
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
0 USD
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-36000 USD
CY2013Q2 us-gaap Severance Costs1
SeveranceCosts1
0 USD
CY2012Q2 us-gaap Severance Costs1
SeveranceCosts1
0 USD
us-gaap Severance Costs1
SeveranceCosts1
0 USD
us-gaap Severance Costs1
SeveranceCosts1
0 USD
us-gaap Severance Costs1
SeveranceCosts1
168000 USD
CY2012Q2 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
35000 USD
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-312000 USD
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-96000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
10298000 USD
CY2013Q2 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-10000 USD
CY2012Q2 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
68000 USD
CY2013Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
CY2012Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
CY2013Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-889000 USD
CY2012Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1133000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1296000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1711000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-86333000 USD
CY2013Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
CY2012Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1440000 USD
CY2013Q2 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
CY2012Q2 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
115000 USD
CY2013Q2 us-gaap Proceeds From Sale Of Other Productive Assets
ProceedsFromSaleOfOtherProductiveAssets
0 USD
CY2012Q2 us-gaap Proceeds From Sale Of Other Productive Assets
ProceedsFromSaleOfOtherProductiveAssets
0 USD
us-gaap Proceeds From Sale Of Other Productive Assets
ProceedsFromSaleOfOtherProductiveAssets
0 USD
us-gaap Proceeds From Sale Of Other Productive Assets
ProceedsFromSaleOfOtherProductiveAssets
0 USD
us-gaap Proceeds From Sale Of Other Productive Assets
ProceedsFromSaleOfOtherProductiveAssets
24000 USD
CY2013Q2 adhxf Withdrawals From Restricted Cash
WithdrawalsFromRestrictedCash
0 USD
CY2012Q2 adhxf Withdrawals From Restricted Cash
WithdrawalsFromRestrictedCash
0 USD
adhxf Withdrawals From Restricted Cash
WithdrawalsFromRestrictedCash
0 USD
adhxf Withdrawals From Restricted Cash
WithdrawalsFromRestrictedCash
0 USD
adhxf Withdrawals From Restricted Cash
WithdrawalsFromRestrictedCash
190000 USD
CY2013Q2 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
0 USD
CY2012Q2 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
0 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
0 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
0 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
209000 USD
CY2013Q2 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0 USD
CY2012Q2 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
22148000 USD
CY2013Q2 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
0 USD
CY2012Q2 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
0 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
0 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
0 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
22791000 USD
CY2013Q2 us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
0 USD
CY2012Q2 us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
0 USD
us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
0 USD
us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
0 USD
us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
166000 USD
CY2013Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
CY2012Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
640000 USD
CY2013Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
CY2012Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1483000 USD
CY2013Q2 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
CY2006Q4 us-gaap Stockholders Equity
StockholdersEquity
1268000 USD
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
-4926000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
0 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
65000 USD
CY2013Q2 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
0 USD
CY2012Q2 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
0 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
0 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
8000 USD
CY2013Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
CY2012Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
465000 USD
CY2013Q2 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
CY2012Q2 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
3017000 USD
CY2013Q2 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
0 USD
CY2012Q2 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
0 USD
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
0 USD
CY2013Q2 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
544000 USD
us-gaap Proceeds From Other Deposits
ProceedsFromOtherDeposits
0 USD
us-gaap Proceeds From Other Deposits
ProceedsFromOtherDeposits
0 USD
us-gaap Proceeds From Other Deposits
ProceedsFromOtherDeposits
35000 USD
CY2013Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
CY2012Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
51000 USD
CY2013Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 USD
CY2012Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
88445000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
378000 USD
CY2013Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-889000 USD
CY2012Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1133000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1296000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1711000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1007000 USD
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1896000 USD
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4719000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5297000 USD
CY1996Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3586000 USD
adhxf Proceeds From Issuance Of Commonstock Net O Fexpenses
ProceedsFromIssuanceOfCommonstockNetOFexpenses
0 USD
adhxf Proceeds From Issuance Of Commonstock Net O Fexpenses
ProceedsFromIssuanceOfCommonstockNetOFexpenses
0 USD
adhxf Proceeds From Issuance Of Commonstock Net O Fexpenses
ProceedsFromIssuanceOfCommonstockNetOFexpenses
86443000 USD
us-gaap Net Income Loss
NetIncomeLoss
-37000 USD
CY1997Q2 us-gaap Stockholders Equity
StockholdersEquity
-37000 USD
CY1998 us-gaap Net Income Loss
NetIncomeLoss
-398000 USD
CY1998Q2 us-gaap Stockholders Equity
StockholdersEquity
-435000 USD
CY1999 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1615000 USD
CY1999 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
20000 USD
CY1999 us-gaap Net Income Loss
NetIncomeLoss
-958000 USD
CY1999Q2 us-gaap Stockholders Equity
StockholdersEquity
242000 USD
CY2000 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
793000 USD
CY2000 adhxf Equity Rights Offering
EquityRightsOffering
171000 USD
CY2000 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
16000 USD
CY2000 us-gaap Net Income Loss
NetIncomeLoss
-1605000 USD
CY2000Q2 us-gaap Stockholders Equity
StockholdersEquity
47000 USD
CY2001 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
182000 USD
CY2001 us-gaap Net Income Loss
NetIncomeLoss
-2524000 USD
CY2001Q2 us-gaap Stockholders Equity
StockholdersEquity
9792000 USD
CY2002 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
11000 USD
CY2002 us-gaap Net Income Loss
NetIncomeLoss
-3732000 USD
CY2003 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4000 USD
CY2003 us-gaap Dividends Cash
DividendsCash
-158000 USD
CY2003 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
1058000 USD
CY2003 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-159000 USD
CY2003 us-gaap Net Income Loss
NetIncomeLoss
-17795000 USD
CY2003Q2 us-gaap Stockholders Equity
StockholdersEquity
698000 USD
CY2004 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
1983000 USD
CY2004 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
23000 USD
CY2004 adhxf Stock Issued During Period Value Merger
StockIssuedDuringPeriodValueMerger
-22000 USD
CY2004 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-219000 USD
CY2004 us-gaap Net Income Loss
NetIncomeLoss
-6872000 USD
CY2004Q2 us-gaap Stockholders Equity
StockholdersEquity
20454000 USD
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
-493000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1392000 USD
us-gaap Net Income Loss
NetIncomeLoss
-6594000 USD
CY2004Q4 us-gaap Stockholders Equity
StockholdersEquity
16654000 USD
CY2005 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
25000 USD
CY2005 us-gaap Net Income Loss
NetIncomeLoss
-13871000 USD
CY2006 us-gaap Net Income Loss
NetIncomeLoss
-16440000 USD
CY2008 us-gaap Net Income Loss
NetIncomeLoss
-13600000 USD
CY2007 us-gaap Net Income Loss
NetIncomeLoss
-13357000 USD
CY2009 us-gaap Net Income Loss
NetIncomeLoss
-3012000 USD
CY2010 us-gaap Net Income Loss
NetIncomeLoss
-7824000 USD
CY2005Q4 us-gaap Stockholders Equity
StockholdersEquity
11077000 USD
CY2007Q4 us-gaap Stockholders Equity
StockholdersEquity
14148000 USD
CY2008Q4 us-gaap Stockholders Equity
StockholdersEquity
3053000 USD
CY2009Q4 us-gaap Stockholders Equity
StockholdersEquity
406000 USD
CY2007 adhxf Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
694000 USD
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
-120000 USD
CY2013Q1 us-gaap Stockholders Equity
StockholdersEquity
-9065000 USD
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-5163000 USD
CY2011 us-gaap Net Income Loss
NetIncomeLoss
4685000 USD
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-4108000 USD
CY2005 us-gaap Stockholders Equity Other
StockholdersEquityOther
-141000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong>Use of estimates</strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"><font size="2">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that impact the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as at the date of the consolidated financial statements and the reported amounts of revenue and expense during the reporting period. Significant estimates include certain accruals, valuation of derivative warrant liability and the value of stock based compensation. Actual results could differ from those estimates.</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"><font size="2">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> In the opinion of management, these unaudited interim consolidated financial statements include all normal and recurring adjustments, considered necessary for the fair presentation of the Company&#8217;s financial position at June 30, 2013, and to state fairly the results for the periods presented. The most significant estimates included in these financial statements are the derivative instruments described in Note 3. There were significant changes in their valuation during the quarter.</div> </div>
CY2013Q2 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
913 USD
CY2013Q2 us-gaap Cash
Cash
94 USD
CY2013Q2 us-gaap Cash
Cash
13 CAD
CY2013Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
18035 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
51 USD
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
95 USD
CY2013Q2 adhxf Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights
1.44
adhxf Class Of Warrant Or Right Outstanding Weighted Average Remaining Contractual Terms
ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerms
P2Y
CY2010Q2 adhxf Percentage Of Common Shares Outstanding
PercentageOfCommonSharesOutstanding
0.25 pure
CY2013Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
29 USD
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
29 USD
CY2012Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
52 USD
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
52 USD
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.012 pure
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0132 pure
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.01125 pure
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0125 pure
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
1.59 pure
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
1.63 pure
CY2013Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y
CY2012Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y
CY2013Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
1007 USD
CY2013Q2 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
2678 USD
CY2013Q2 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
3685 USD

Files In Submission

Name View Source Status
0001144204-13-044104-index-headers.html Edgar Link pending
0001144204-13-044104-index.html Edgar Link pending
0001144204-13-044104.txt Edgar Link pending
0001144204-13-044104-xbrl.zip Edgar Link pending
adhxf-20130630.xml Edgar Link completed
adhxf-20130630.xsd Edgar Link pending
adhxf-20130630_cal.xml Edgar Link unprocessable
adhxf-20130630_def.xml Edgar Link unprocessable
adhxf-20130630_lab.xml Edgar Link unprocessable
adhxf-20130630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
image_001.jpg Edgar Link pending
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R20.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R21.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R22.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R23.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R24.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R25.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R26.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R27.xml Edgar Link unprocessable
R28.htm Edgar Link pending
R28.xml Edgar Link unprocessable
R29.htm Edgar Link pending
R29.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending
v351840_10q.htm Edgar Link pending
v351840_ex31-1.htm Edgar Link pending
v351840_ex31-2.htm Edgar Link pending
v351840_ex32-1.htm Edgar Link pending
v351840_ex99-1.htm Edgar Link pending